- What is Liposphere's primary focus?
- Liposphere is a biomedical startup developing a platform of highly lubricous, water-based biocompatible nanomaterials for conditions in the human body where ultra-low friction is important.
- What products is Liposphere developing?
- Liposphere is developing AqueousJoint, an orthopedic biolubricant product targeting osteoarthritis as an intra-articular injectable, and an ophthalmic formulation for the treatment of dry eye syndrome.
- What is the potential future application of Liposphere's formulation?
- Liposphere's formulation has the potential to encapsulate active pharmaceutical ingredients for the delivery of pharmaceuticals to difficult-to-reach targets.
- How does Liposphere's platform technology apply to medical devices?
- Liposphere's platform technology enables the coating of artificial medical surfaces such as contact lenses, catheters, and prostheses, providing smooth movement in a wide range of biomedical devices.
- When was Liposphere founded?
- Liposphere was founded in February 2019.
- How many employees does Liposphere have?
- Liposphere has 11-50 employees.
- Who are the co-founders of Liposphere?
- The co-founders of Liposphere are Ronit Goldberg (Co-founder & CEO) and Sabrina Jahn (Co-founder & Business Development).
- Has Liposphere secured any funding?
- In June 2019, Liposphere received a grant from the Israel Innovation Authority. In November 2019, the company received funding from Daniel Gamsu.
- What is Liposphere's current product stage?
- Liposphere's product is currently in the released stage.